Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-000183
Filing Date
2019-01-02
Accepted
2019-01-02 19:23:52
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4076
  Complete submission text file 0000899243-19-000183.txt   5606
Mailing Address C/O TARGANTA THERAPEUTICS CORPORATION 225 SOUTH EAST STREET, SUITE 390 INDIANAPOLIS IN 46202
Business Address
Parr Thomas R JR (Reporting) CIK: 0001413008 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38266 | Film No.: 19503269

Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Issuer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations